MX9803217A - Method of mobilizing hematopoietic stem cells. - Google Patents

Method of mobilizing hematopoietic stem cells.

Info

Publication number
MX9803217A
MX9803217A MX9803217A MX9803217A MX9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A
Authority
MX
Mexico
Prior art keywords
stem cells
hematopoietic stem
mobilizing hematopoietic
gro
mobilizing
Prior art date
Application number
MX9803217A
Other languages
Spanish (es)
Other versions
MXPA98003217A (en
Inventor
Louis Martin Pelus
Andrew Garrison King
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9803217A publication Critical patent/MX9803217A/en
Publication of MXPA98003217A publication Critical patent/MXPA98003217A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/522Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method of mobilizing hematopoietic stem cells from the bone marrow to the peripheral circulation is provided by administering to an animal an effective amount of nature, modified or multimeric forms of KC, gro'beta', gro'alpha' or gro'gamma'.
MXPA/A/1998/003217A 1995-10-24 1998-04-23 Method of mobilization of hematopoyetic mother cells MXPA98003217A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54726295A 1995-10-24 1995-10-24
US547262 1995-10-24

Publications (2)

Publication Number Publication Date
MX9803217A true MX9803217A (en) 1998-09-30
MXPA98003217A MXPA98003217A (en) 1998-11-16

Family

ID=

Also Published As

Publication number Publication date
ZA968896B (en) 1997-04-24
NO981818D0 (en) 1998-04-23
EP0866806A4 (en) 2002-01-09
CZ120298A3 (en) 1998-09-16
HUP9802531A2 (en) 1999-02-01
PL326364A1 (en) 1998-09-14
EP0866806A1 (en) 1998-09-30
BR9611173A (en) 1999-03-30
NZ321789A (en) 2000-07-28
AU712235B2 (en) 1999-11-04
JPH11512747A (en) 1999-11-02
TR199800742T2 (en) 1998-08-21
KR19990066997A (en) 1999-08-16
WO1997015595A1 (en) 1997-05-01
AU7520996A (en) 1997-05-15
NO981818L (en) 1998-06-17
HUP9802531A3 (en) 2001-08-28
AR004093A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
IL72643A (en) Gene encoding an analog of human interleukin-ii which substantially retains the biological activity of natural human interleukin-ii,microorganism expression vector containing the gene,microorganisms transformed by the vector and the human interleukin-ii analog produced by the microorganisms
ES8307263A1 (en) Substituted phosphonamides, a process for preparing the same and a pharmaceutical composition which is useful in the treatment of hypertension.
AU6760987A (en) Method of treating alzheimer's disease
ZA9810444B (en) Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease
ES8900017A1 (en) N,N-dialkylguanidino dipeptides.
ES8606289A1 (en) Anti-virally active pyridazinamines.
GB8912330D0 (en) Live vaccines
OA07021A (en) Method of inclusion of microorganisms from the group of mycorrhizae and actinorrhizae.
BE1002196A3 (en) BACTERIAL TREATMENT TO PROTECT THE QUALITY OF HAY BY ADDITION OF MICROORGANISMS OF THE GENUS BACILLUS.
IT1217828B (en) FERMENTATION DEVICE FOR THE AEROBIC CULTURE OF MICROORGANISMS
HUT55613A (en) Process for improving the fodder utilization of animals by the application of bacteriolysing enzymes and proteases
EP0139468A3 (en) Hair treatment composition
EP0219782A3 (en) Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
NO981818L (en) Procedure for Mobilizing Hematopoietic Stem Cells
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
GB9410639D0 (en) Method of improving fertilization
ES8609461A1 (en) Method and compositions for use in the treatment of fireblight.
ES8800725A1 (en) Monoclonal antibodies to tissue plasminogen activator derived from human normal cells.
ES2038642T3 (en) DERMIC TREATMENT OF VERMICULAR DISEASES OF THE CAT WITH PRACICUANTEL.
DE69625910D1 (en) PENAMSULPHONES AS BETA LACTAMASE INHIBITORS
IT9022010A0 (en) PROCEDURE FOR THE USE OF ORGANIC WASTE FOR THE PRODUCTION OF BIOGAS AND AGRICULTURAL PRODUCTS.
ES8706202A1 (en) Use of efomycines for increasing the efficiency by animals, efomycines and their preparation.
ATE248218T1 (en) HUMAN HYPERTROPHIC CHRONDROCYTE CELL LINES
IT1217825B (en) PROCEDURE AND PLANT FOR THE CULTURE OF MICROORGANISMS
SE8601421L (en) HAIR TREATMENTS AND PROCEDURES FOR COSMETIC TREATMENT OF HAIR AND RESIN

Legal Events

Date Code Title Description
FA Abandonment or withdrawal